Nuvation Bio prices $250M convertible notes offering due 2032 Jun 25, 2026 11:59PM
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes Jun 25, 2026 11:58PM
Nuvation Bio plans $200M convertible notes offering due 2032 Jun 25, 2026 07:02AM
Nuvation Bio Announces Proposed Convertible Senior Notes Offering Jun 25, 2026 07:00AM
Nuvation Bio to Participate in Upcoming Investor Conferences Nov 26, 2025 04:05PM


Aug 27, 2025 04:05PM Nuvation Bio to Participate in Upcoming Investor Conferences
Jun 25, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)
Jun 13, 2025 05:31AM Citizens JMP Reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)
Jun 12, 2025 04:13AM Citizens JMP Reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)
Jun 2, 2025 04:05AM Citizens JMP Reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
Apr 23, 2025 02:55AM Citizens JMP Starts Nuvation Bio Inc (NUVB) at Market Outperform
Aug 11, 2022 10:01AM ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox
Mar 11, 2021 05:15PM Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update